AC Immune SA at Jefferies Healthcare Conference Transcript
Okay. Good morning and welcome to day-2 of the Jefferies New York Healthcare Conference. My name is Lucy Codrington; I'm one of the European pharma and biotech analysts based in London. It is my pleasure to introduce Andrea Pfeifer, the CEO of AC Immune. Andrea is going to kick off with a short presentation and then we're going to move to a fireside chat. So with that, I'll hand over to Andrea.
Yeah. Good morning. I'm very happy that you could join. I'm pleased to be here in person and present to you AC Immune, a company focusing on the precision medicine in neurodegenerative diseases. Today, I will give you a short update on our pipeline, speak about very focused growth initiatives, and give you an insight into the clinical program in diagnostic and therapeutics and then end up with a short review of our milestones remaining for this year.
This is a disclaimer. So just as a reminder, AC Immune's value is really related to a pipeline, which is one of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |